F Grimminger, H Wahn, K Mayer, L Kiss, D Walmrath and W Seeger
Department of Internal Medicine, Justus-Liebig-University, Giessen, Germany.

Escherichia coli hemolysin (HlyA) is a proteinaceous pore-forming exotoxin that is implicated as a significant pathogenicity factor in extraintestinal E. coli infections including sepsis. In perfused rabbit lungs, subcytolytic concentrations of the toxin evoke thromboxane- mediated vasoconstriction and prostanoid-independent protracted vascular permeability increase (11). In the present study, the influence of submicromolar concentrations of free arachidonic acid (AA) and eicosapentaenoic acid (EPA) on the HlyA-induced leakage response was investigated. HlyA at concentration from 0.02 to 0.06 hemolytic units/ml provoked a dose-dependent, severalfold increase in the capillary filtration coefficient (Kfc), accompanied by the release of leukotriene(LT)B4, LTC4, and LTE4 into the recirculating buffer fluid. Simultaneous application of 100 nmol/L AA markedly augmented the HlyA- elicited leakage response, concomitant with an amplification of LTB4 release and a change in the kinetics of cysteinyl-LT generation. In contrast, 50 to 200 nmol/L EPA suppressed in a dose-dependent manner the HlyA-induced increase in Kfc values. This was accompanied by a blockage of 4-series LT generation and a dose-dependent appearance of LTB5, LTC5, and LTE5. In addition, EPA fully antagonized the AA-induced amplification of the HlyA-provoked Kfc increase, again accompanied by a shift from 4-series to 5-series LT generation. We conclude that the vascular leakage provoked by HlyA in rabbit lungs is differentially influenced by free AA versus free EPA, related to the generation of 4- versus 5-series leukotrienes. The composition of lipid emulsions used for parenteral nutrition may thus influence inflammatory capillary leakage.

This article has been cited by other articles:

				K. M. Gura, S. Lee, C. Valim, J. Zhou, S. Kim, B. P. Modi, D. A. Arsenault, R. A. M. Strijbosch, S. Lopes, C. Duggan, et al. Safety and Efficacy of a Fish-Oil-Based Fat Emulsion in the Treatment of Parenteral Nutrition-Associated Liver Disease Pediatrics, March 1, 2008; 121(3): e678 - e686. [Abstract] [Full Text] [PDF]

				S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids Nutr Clin Pract, August 1, 2006; 21(4): 323 - 341. [Abstract] [Full Text] [PDF]

				K. Mayer, S. Gokorsch, C. Fegbeutel, K. Hattar, S. Rosseau, D. Walmrath, W. Seeger, and F. Grimminger Parenteral Nutrition with Fish Oil Modulates Cytokine Response in Patients with Sepsis Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1321 - 1328. [Abstract] [Full Text] [PDF]

				E. J. Giamarellos-Bourboulis, D. Plachouras, S. Skiathitis, M. Raftogiannis, A. Dionyssiou-Asteriou, I. Dontas, P. E. Karayannacos, and H. Giamarellou Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa J. Antimicrob. Chemother., February 1, 2003; 51(2): 423 - 426. [Abstract] [Full Text] [PDF]

				H Wahn, N Ruenauver, and S Hammerschmidt Effect of arachidonic and eicosapentaenoic acids on acute lung injury induced by hypochlorous acid Thorax, December 1, 2002; 57(12): 1060 - 1066. [Abstract] [Full Text] [PDF]

				L. KISS, H. SCHÜTTE, K. MAYER, H. GRIMM, W. PADBERG, W. SEEGER, and F. GRIMMINGER Synthesis of Arachidonic Acid-Derived Lipoxygenase and Cytochrome P450 Products in the Intact Human Lung Vasculature Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1917 - 1923. [Abstract] [Full Text]

				M. Ermert, M. Merkle, R. Mootz, F. Grimminger, W. Seeger, and L. Ermert Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1195 - L1203. [Abstract] [Full Text] [PDF]